Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01990287 · ClinicalTrials.gov registry record · NA

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study

A NA study, sponsored by Abbott Medical Devices.

Terminated
Registry status
NA
Development phase
38
Enrollment target

NCT01990287 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01990287, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.

TERMINATED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The purpose of the study is to demonstrate safety and efficacy of spinal cord stimulation with peripheral nerve field stimulation for the treatment of chronic low back and leg pain.

Interventions

  • DEVICE SCS and PNfS
  • DEVICE SCS Alone

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2013-11
Est. Completion 2016-02
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT01990287

The ClinicalTrials.gov registry entry for NCT01990287 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which SCS and PNfS is the first listed.

NCT01990287 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01990287 about?

NCT01990287 is a clinical study titled "SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study". The purpose of the study is to demonstrate safety and efficacy of spinal cord stimulation with peripheral nerve field stimulation for the treatment of chronic low back and leg pain.

What is the current status of trial NCT01990287?

This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2013-11. Estimated completion is 2016-02.

What interventions are being tested in trial NCT01990287?

The interventions under investigation include: SCS and PNfS (DEVICE), SCS Alone (DEVICE).

Who is sponsoring clinical trial NCT01990287?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.